Biopôle Clermont-Limagne
Technology park for life sciences
Year of creation : 1993
Statut : simplified joint stock company
Size : 31
% of CA dedicated to R&D : 10
Patents (number of) : 0

Contact details

Biopôle Clermont-Limagne
13 rue Henri Mondor
63360 Saint-Beauzire



Contact : Hubert Guibourt
Phone : +33 473 981 428
Email : info@ost-dev.com
Website : www.ost-laboratoires.com

OST Développement

O.S.T laboratories manufacture and market bone substitutes used by orthopaedic surgeons and dental surgeons.


 

For more than 25 years, O.S.T laboratories have been manufacturing and marketing bone replacements used by orthopedic surgeons and dental surgeons in filling or interposition grafting procedures.

The company specializes in the production of bone grafts derived from natural bone from an animal commonly known as a xenograft or a human donor known as an allograft, and the company’s reputation is based on the mastery of the processes used to treat this natural bone whose intrinsic qualities are exceptional in order to obtain a finished product that is both extremely safe, high performance and easy to use.

A bone processing process such as the Ostéopure® process that we developed and patented is a series of cutting and shaping operations performed by experienced staff and chemical processing steps that are rigorously designed and widely automated, the whole being carried out in zones with a controlled atmosphere.

The products we manufacture, marketed under the brands Allodyn®, Osteopure® or Arcuate®, are implanted daily throughout France and abroad. Thanks to our research and partnership activities, through innovative solutions such as growth factors or 3D printing, we position ourselves as a European leader in bone regeneration.